high-performance temperature-controlled packaging systems

How packaging choices can cut the carbon footprint of pharmaceutical cold chains

Packaging choice can change the carbon footprint of a temperature-controlled pharmaceutical shipment by up to 2.8 times, according to a KEDGE Business School study led by Professor Yann Bouchery. Transportation of the loaded shipment dominates emissions, so lightweight design, real-world reusability and maritime repositioning are the three characteristics of the lowest-emission packaging.

PPWR and pharmaceutical cold-chain packaging: what companies need to know

The Packaging and Packaging Waste Regulation (PPWR), Regulation (EU) 2025/40, introduces a harmonised European framework for packaging and packaging waste. It applies from 12 August 2026, with additional requirements coming into force progressively over the next few years.

For pharmaceutical and life-sciences supply chains, the PPWR increases the importance of packaging optimisation, recyclability, reuse, material information and technical documentation. For temperature-sensitive healthcare products, these requirements must be considered alongside the essential thermal and mechanical performance of the packaging.

Deep Freeze VYPE by EMBALL’ISO: the PREMIUM+ insulated packaging solution

Deep Freeze VYPE is EMBALL’ISO’s PREMIUM+ reusable insulated packaging solution, designed for shipping packages at very low temperatures (< –70°C), with a temperature hold time of up to 244 hours (more than 10 days) without re-icing. This extended autonomy significantly reduces logistics costs associated with dry ice replenishment while helping secure the cold chain.

Fill in your details to download our brochure